{ "items": [ "\n\n
Professor Deborah Goberdhan (Department of Physiology, Anatomy, and Genetics) received money from the John Fell Fund to support her work investigating exosome switching. Find out more about Professor Goberdhan's research, and about how it was advanced by the John Fell Fund.
\n \n\n \n \nDr Manisha Nair and Prof. Marian Knight (Nuffield Department of Population Health) received a grant from the John Fell Fund to support their work in establishing an obstetric research system, based upon a UK model, in Assam, India. Hear Dr. Nair speak about the research, and how the John Fell Fund supported it.
\n \n\n \n \nProfessor Charlie Stagg (Nuffield Department of Clinical Neurosciences) discusses how Wellcome ISSF and John Fell Funding allowed her group to establish world-leading neurophysiological resources at Oxford.
\n \n\n \n \nProfessor Kevin Marsh (Nuffield Department of Clinical Medicine) successfully applied to the Wellcome ISSF for a grant to establish the Africa Oxford Initiative (AfOx), a platform to encourage collaboration between the University of Oxford and African institutions. Hear more about the initiative from Kevin and Dr Anne Makena, the AfOx Programme Coordinator.
\n \n\n \n \nProfessor Arturo Reyes-Sandoval (Nuffield Department of Clinical Medicine) was awarded Medical Research Council Confidence in Concept funding for his project to develop a new vaccine against dengue fever. Listen to him speak about his research and experience of funding.
\n \n\n \n \nDr Sridhar Vasudevan (Department of Pharmacology) received Medical Research Council Confidence in Concept funding to investigate a series of drugs which could be used to modulate and treat circadian rhythm disorders. He discusses his research, and how this funding enabled him to accelerate his successes.
\n \n\n \n \nDr Katie Warnaby (Nuffield Department of Clinical Neurosciences) received Medical Research Council Confidence in Concept funding to develop a new technique for measuring depth of anaesthesia in patients. She discusses her research, and what she was able to achieve with the funding.
\n \n\n \n \nThe University of Oxford Medical Sciences Division has a variety of internal funds which it can deploy to support research. Explore projects which have previously received funding from the Wellcome ISSF, John Fell Fund, and MRC Confidence in Concept.
\n \n\n \n \nNNRCO comprises an Operations Department and the following Research Departments:
\n \n\n \n \nNovo Nordisk is the world\u2019s leading diabetes therapeutics company, with 95 years of experience of innovation in diabetes care. The company has a longstanding relationship with the University of Oxford, itself a global leader in metabolism research, and in 2017 the Novo Nordisk Research Centre Oxford (NNRCO) was launched as part of a strategic alliance between the two organisations.
\n \n\n \n \n